# DESCRIPTION

## 1. TECHNICAL FIELD

- introduce glio-vascular pathway function

## 2. BACKGROUND OF THE INVENTION

- describe lymphatic vasculature and brain waste clearance

## 3. SUMMARY OF THE INVENTION

- introduce glymphatic system function measurement
- describe imaging and CSF-ISF exchange measurement
- outline method embodiments
- describe imaging agents and administration
- outline CSF-ISF exchange measurement embodiments
- describe data analysis and kinetic parameter calculation
- outline neurodegenerative disease treatment embodiments
- describe glymphatic clearance increase methods

## 5. DETAILED DESCRIPTION OF THE INVENTION

- describe methods for measuring and treating neurodegenerative diseases

### 5.1. Methods for Measuring Glio-Vascular Pathway (Glymphatic System) Function in the Brain

- introduce method for measuring glymphatic function
- describe imaging of central nervous system
- measure CSF-ISF exchange in central nervous system
- administer imaging agent or contrast agent
- analyze influx kinetics and clearance of imaging agent
- calculate risk of developing neurodegenerative disease
- describe specific embodiments of method

### 5.2. Methods for Treating Onset of a Neurodegenerative Disease

- describe method for treating neurodegenerative disease by increasing glymphatic clearance

### 5.3. Methods for Promoting Clearance of a Brain Waste Product from Brain Interstitium

- describe method for promoting clearance of brain waste product by increasing glymphatic clearance

### 5.4. Methods for Slowing, Delaying or Preventing Accumulation of a Brain Waste Product

- describe method for slowing, delaying or preventing accumulation of brain waste product by increasing glymphatic clearance

### 5.5. Methods for Decreasing or Impeding Clearance of a Therapeutic or Modulatory Agent from the Brain Interstitium of a Mammal

- outline method for impeding clearance

### 5.6. Therapeutic Uses of Methods

- discuss therapeutic applications

## 6. EXAMPLES

### 6.1. Example 1

- introduce paravascular pathway for CSF flow and solute clearance
- describe limitations of current understanding of CSF flow
- outline experimental approach using in vivo two-photon imaging
- describe animal models and anesthesia procedures
- outline CSF tracer injection and imaging protocols
- describe ex vivo fluorescence imaging and analysis
- outline in vivo 2-photon laser scanning microscopy
- describe intraparenchymal tracer injection and clearance protocols
- outline immunofluorescence and electron microscopic cytochemistry
- introduce CSF influx into brain parenchyma
- demonstrate paravascular CSF influx and clearance
- show astroglial water transport supports CSF flux
- demonstrate astroglial water transport facilitates bulk ISF solute clearance
- show AQP4-dependent ISF bulk flow contributes to clearance of soluble Aβ
- demonstrate soluble Aβ recirculates through brain parenchyma
- quantify fluorescent CSF tracer distribution within brain parenchyma
- measure subarachnoid CSF entry into brain parenchyma
- describe experimental design
- present results of CSF influx and clearance experiments
- discuss implications of findings for glymphatic pathway
- compare results to previous studies
- highlight role of AQP4 in paravascular pathway function
- describe AQP4-dependent astroglial water flux
- illustrate paravascular CSF influx and ISF clearance
- introduce Alzheimer's disease and Aβ clearance
- describe paravascular pathways and AQP4-dependent bulk flow
- discuss significance of bulk flow for interstitial solute clearance
- motivate therapeutic approaches based on paravascular pathways
- summarize references cited in Example 1
- describe the importance of paravascular pathways in humans
- discuss the role of AQP4 in brain function and disease
- conclude significance of paravascular pathways and AQP4-dependent bulk flow

### 6.2. Example 2

- introduce glymphatic system
- describe CSF-ISF exchange and clearance
- motivate MRI imaging for brain-wide CSF-ISF exchange
- describe surgical preparation for MRI imaging
- outline MRI imaging protocol
- detail data processing and analysis
- describe cluster analysis for glymphatic pathway visualization
- outline fluorescent intrathecal tracer imaging
- summarize results of glymphatic pathway imaging
- describe example 2
- illustrate influx of contrast agents
- analyze effect of molecular size on transport
- compare brain-wide distribution of Gd-DTPA and GadoSpin
- perform cluster analysis of brain tissue uptake
- describe fluorescence-based imaging of glymphatic pathway function
- describe fluorescent tracer distribution
- discuss glymphatic pathway function
- analyze CSF-ISF exchange patterns
- compare contrast agents
- discuss limitations of MRI imaging
- propose clinical application of contrast-enhanced MRI
- cite references

### 6.3. Example 3

- motivate glymphatic pathway function evaluation
- describe limitations of current approaches
- summarize example methodology
- detail fluorescence imaging and quantification
- discuss results and implications
- introduce glymphatic system
- describe CSF-ISF exchange in rat brain
- compare intracisternal and lumbar injection routes
- analyze fluorescent CSF tracer influx into brain parenchyma
- evaluate effect of molecular weight on tracer influx
- describe paravascular pathway of CSF tracer influx
- conclude findings on glymphatic pathway function
- discuss implications for Alzheimer's disease
- reference cited studies

### 6.4. Example 4

- introduce cerebrospinal fluid (CSF) secretion and flow
- motivate Alzheimer's disease (AD) and its relation to CSF
- describe glymphatic system and its role in CSF/ISF exchange
- outline experimental design and methods
- present results of CSF infusion on Aβ40 and inulin clearance
- discuss implications of restoring CSF flow for AD treatment

### 6.5 Example 5

- describe methods for evaluating glymphatic transport using PET and MRI
- outline clinical protocol for assessing glymphatic transport in human brain

### 6.6 Example 6

- demonstrate impaired glymphatic pathway function in aging brain
- evaluate glymphatic pathway function by ex vivo fluorescence imaging
- show region-specific age-related impairment of glymphatic pathway function
- evaluate impairment of interstitial amyloid β clearance in aging brain
- demonstrate reduced cerebral arterial pulsation in aging brain
- evaluate changes in cortical extracellular volume fraction and tortuosity in aging brain
- show altered perivascular AQP4 expression and polarization in aging brain
- present experimental results
- demonstrate impaired glymphatic pathway function after TBI
- show Aqp4 gene deletion exacerbates TBI-induced tauopathy
- illustrate impairment of glymphatic pathway function promotes tau aggregation
- evaluate effect of Aqp4 gene deletion on post-traumatic cognitive impairment
- investigate AQP4-M1 variant as a determinant of perivascular AQP4 polarization

### 6.7 Example 7

- motivate glymphatic system as target for brain-wide clearance
- describe background of Alzheimer's disease and Aβ accumulation
- explain fluid balance in the periphery and renin-angiotensin system (RAS)
- describe brain RAS and its role in controlling fluid environment
- hypothesize RAS role in clearance of ISF substances via glymphatic system
- describe methods for brain clearance studies and tissue sampling
- present results of pharmacological interventions on Aβ and inulin clearance
- summarize effects of various compounds on glymphatic system and clearance
- describe glymphatic system clearance
- demonstrate effects of mechanical disruption and sleep deprivation
- propose treatment using sleep aids
- list references cited in example 7

### 6.8 Example 8

- introduce AQP4 modulation of amyloid beta clearance
- describe neurodegenerative diseases and AQP4 polarization
- motivate JNJ-17299425 and JNJ-17306861 as therapeutic agents
- describe proof-of-concept studies and testing of JNJ-17299425 and JNJ-17306861
- outline methods for measuring glymphatic system function
- describe methods for treating neurodegenerative diseases by increasing glymphatic clearance
- outline methods for promoting clearance of waste products from the central nervous system
- describe methods for treating the brain by increasing glymphatic clearance
- outline methods for decreasing or impeding clearance of therapeutic agents from the brain interstitium

